These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 27475248)
1. Urinary KIM-1, but not urinary cystatin C, should be corrected for urinary creatinine. Helmersson-Karlqvist J; Ärnlöv J; Carlsson AC; Lind L; Larsson A Clin Biochem; 2016 Oct; 49(15):1164-1166. PubMed ID: 27475248 [TBL] [Abstract][Full Text] [Related]
2. Day-to-day variation of urinary NGAL and rational for creatinine correction. Helmersson-Karlqvist J; Arnlöv J; Larsson A Clin Biochem; 2013 Jan; 46(1-2):70-2. PubMed ID: 23041245 [TBL] [Abstract][Full Text] [Related]
3. Day-to-day variation of the kidney proximal tubular injury markers urinary cystatin C, KIM1, and NGAL in patients with chronic kidney disease. Soveri I; Helmersson-Karlqvist J; Fellström B; Larsson A Ren Fail; 2020 Nov; 42(1):400-404. PubMed ID: 32349578 [No Abstract] [Full Text] [Related]
4. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635 [TBL] [Abstract][Full Text] [Related]
5. Clinical utility of urine kidney injury molecule-1 (KIM-1) and gamma-glutamyl transferase (GGT) in the diagnosis of canine acute kidney injury. Lippi I; Perondi F; Meucci V; Bruno B; Gazzano V; Guidi G Vet Res Commun; 2018 Jun; 42(2):95-100. PubMed ID: 29427053 [TBL] [Abstract][Full Text] [Related]
6. Investigating the Value of Urine Volume, Creatinine, and Cystatin C for Urinary Biomarkers Normalization for Drug Development Studies. Adedeji AO; Pourmohamad T; Chen Y; Burkey J; Betts CJ; Bickerton SJ; Sonee M; McDuffie JE Int J Toxicol; 2019; 38(1):12-22. PubMed ID: 30673360 [TBL] [Abstract][Full Text] [Related]
7. Decrease in urinary creatinine in acute kidney injury influences diagnostic value of urinary biomarker-to-creatinine ratio in rats. Tonomura Y; Uehara T; Yamamoto E; Torii M; Matsubara M Toxicology; 2011 Dec; 290(2-3):241-8. PubMed ID: 22005293 [TBL] [Abstract][Full Text] [Related]
8. Urinary cystatin C levels as a diagnostic and prognostic biomarker in patients with acute kidney injury. Park MY; Choi SJ; Kim JK; Hwang SD; Lee YW Nephrology (Carlton); 2013 Apr; 18(4):256-62. PubMed ID: 23414098 [TBL] [Abstract][Full Text] [Related]
9. Urinary KIM-1, IL-18 and Cys-c as early predictive biomarkers in gadolinium-based contrast-induced nephropathy in the elderly patients. Duan SB; Liu GL; Yu ZQ; Pan P Clin Nephrol; 2013 Nov; 80(5):349-54. PubMed ID: 24040783 [TBL] [Abstract][Full Text] [Related]
10. Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. Zhang PL; Mashni JW; Sabbisetti VS; Schworer CM; Wilson GD; Wolforth SC; Kernen KM; Seifman BD; Amin MB; Geddes TJ; Lin F; Bonventre JV; Hafron JM Int Urol Nephrol; 2014 Feb; 46(2):379-88. PubMed ID: 23979814 [TBL] [Abstract][Full Text] [Related]
11. Urinary KIM-1: a novel biomarker for evaluation of occupational exposure to lead. Zhou R; Xu Y; Shen J; Han L; Chen X; Feng X; Kuang X Sci Rep; 2016 Dec; 6():38930. PubMed ID: 27966578 [TBL] [Abstract][Full Text] [Related]
12. Exploring the Utility of Urinary Creatinine Adjustment for KIM-1, NGAL, and Cystatin C for the Assessment of Kidney Function: Insights from the C-KidnEES Cohort. Gunasekara TDKSC; Herath C; De Silva PMCS; Jayasundara N Children (Basel); 2023 Dec; 11(1):. PubMed ID: 38255329 [TBL] [Abstract][Full Text] [Related]
14. Altered kidney function induced by SARS-CoV-2 infection and acute kidney damage markers predict survival outcomes of COVID-19 patients: a prospective pilot study. Temiz MZ; Hacibey I; Yazar RO; Sevdi MS; Kucuk SH; Alkurt G; Doganay L; Dinler Doganay G; Dincer MM; Yuruk E; Erkalp K; Muslumanoglu AY Ren Fail; 2022 Dec; 44(1):233-240. PubMed ID: 35172674 [TBL] [Abstract][Full Text] [Related]
15. Novel urinary biomarkers and their association with urinary heavy metals in chronic kidney disease of unknown aetiology in Sri Lanka: a pilot study. Wanigasuriya K; Jayawardene I; Amarasiriwardena C; Wickremasinghe R Ceylon Med J; 2017 Dec; 62(4):210-217. PubMed ID: 29390596 [TBL] [Abstract][Full Text] [Related]
16. Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine. Ghys LF; Meyer E; Paepe D; Delanghe J; Daminet S Vet Clin Pathol; 2014 Jun; 43(2):226-34. PubMed ID: 24773065 [TBL] [Abstract][Full Text] [Related]
17. Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Wilson FP; Xie D; Anderson AH; Leonard MB; Reese PP; Delafontaine P; Horwitz E; Kallem R; Navaneethan S; Ojo A; Porter AC; Sondheimer JH; Sweeney HL; Townsend RR; Feldman HI; Clin J Am Soc Nephrol; 2014 Dec; 9(12):2095-103. PubMed ID: 25381342 [TBL] [Abstract][Full Text] [Related]
18. Increased urinary cystatin C indicated higher risk of cardiovascular death in a community cohort. Helmersson-Karlqvist J; Ärnlöv J; Carlsson AC; Härmä J; Larsson A Atherosclerosis; 2014 May; 234(1):108-13. PubMed ID: 24637410 [TBL] [Abstract][Full Text] [Related]
19. The utility of kidney injury molecule-1 as an early biomarker of kidney injury in people living with HIV. Danjuma MI; Al Shokri S; Bakhsh N; Alamin MA; Mohamedali MG; Tamuno I Int J STD AIDS; 2020 Nov; 31(13):1228-1237. PubMed ID: 32951563 [TBL] [Abstract][Full Text] [Related]
20. Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study. Foster MC; Coresh J; Bonventre JV; Sabbisetti VS; Waikar SS; Mifflin TE; Nelson RG; Grams M; Feldman HI; Vasan RS; Kimmel PL; Hsu CY; Liu KD; Clin J Am Soc Nephrol; 2015 Nov; 10(11):1956-63. PubMed ID: 26350438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]